These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 36353482)

  • 1. Impact of Ninjin'yoeito on frailty and short life in klotho-hypomorphic (kl/kl) mice.
    Amitani H; Chiba S; Amitani M; Michihara S; Takemoto R; Han L; Fujita N; Takahashi R; Inui A
    Front Pharmacol; 2022; 13():973897. PubMed ID: 36353482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ninjin'yoeito Improves Genitourinary Symptoms in Patients With Frailty.
    Okui N; Okui MA
    Cureus; 2023 Jun; 15(6):e40767. PubMed ID: 37363115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ninjin'yoeito, a traditional Japanese medicine, attenuates age-related deficits of muscle performance, self-care motivation, and body temperature in C57BL/6 mice.
    Matsubara Y; Miyama Y; Imai R; Oizumi H; Miyazaki S; Haneda E; Mizuno K; Omiya Y; Ikeda Y; Mizoguchi K
    Biosci Biotechnol Biochem; 2022 Jun; 86(7):895-901. PubMed ID: 35396846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetic study of Ninjin'yoeito: Absorption and brain distribution of Ninjin'yoeito ingredients in mice.
    Matsumoto T; Takiyama M; Sakamoto T; Kaifuchi N; Watanabe J; Takahashi Y; Setou M
    J Ethnopharmacol; 2021 Oct; 279():114332. PubMed ID: 34129897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ninjin'yoeito suppressed the onset of arthritis, pain, and muscle atrophy in rheumatoid arthritis model mice.
    Suginohara T; Kawaguchi M; Michihara S; Fujita N; Han LK; Takahashi R
    Front Pharmacol; 2022; 13():974380. PubMed ID: 36601050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of the Effects of Ninjin'yoeito on Physical Frailty in Mice.
    Otsuka S; Fukumaru K; Tani A; Takada S; Kikuchi K; Norimatsu K; Matsuzaki R; Matsuoka T; Sakakima H; Omiya Y; Mizuno K; Matsubara Y; Maruyama I
    Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disuse muscle atrophy-improving effect of ninjin'yoeito in a mouse model.
    Takemoto R; Sejima T; Han LK; Michihara S; Takahashi R
    Neuropeptides; 2021 Dec; 90():102199. PubMed ID: 34610544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between the severity of pre-frailty and the degree of adaptation of Ninjin'yoeito (NYT) on pre-frailty.
    Amitani H; Suzuki H; Kobayashi H; Murayama M; Uto NS; Kuroda E; Kobayashi Y; Kawabe M; Amitani M; Inui A; Marunaka Y
    Front Aging; 2024; 5():1304217. PubMed ID: 38681234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stimulation of functional recovery via neurorepair mechanisms by the traditional Japanese Kampo medicine, Ninjin'yoeito, and physical exercise in a rat ischemic stroke model.
    Tani A; Sakakima H; Otsuka S; Mizuno K; Nakanishi K; Norimatsu K; Takada S; Matsuoka T; Matsuzaki R; Nakakogawa T; Maruyama I
    J Ethnopharmacol; 2023 Feb; 302(Pt B):115927. PubMed ID: 36402237
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Usefulness of Ninjin'yoeito for Chronic Obstructive Pulmonary Disease Patients with Frailty.
    Hirai K; Homma T; Matsunaga T; Akimoto K; Yamamoto S; Suganuma H; Kashima A; Sato H; Ebato T; Miyata Y; Ohta S; Inoue H; Kusumoto S; Suzuki S; Tanaka A; Sagara H
    J Altern Complement Med; 2020 Aug; 26(8):750-757. PubMed ID: 32551796
    [No Abstract]   [Full Text] [Related]  

  • 11. Ninjin'yoeito Ameliorates Skeletal Muscle Complications in COPD Model Mice by Upregulating Peroxisome Proliferator-Activated Receptor γ Coactivator-1α Expression.
    Miyamoto A; Asai K; Kadotani H; Maruyama N; Kubo H; Okamoto A; Sato K; Yamada K; Ijiri N; Watanabe T; Kawaguchi T
    Int J Chron Obstruct Pulmon Dis; 2020; 15():3063-3077. PubMed ID: 33273811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and efficacy of Ninjin'yoeito along with iron supplementation therapy for preoperative anemia, fatigue, and anxiety in patients with gynecological disease: an open-label, single-center, randomized phase-II trial.
    Yagi T; Sawada K; Miyamoto M; Kinose Y; Nakagawa S; Takiuchi T; Kodama M; Kobayashi E; Hashimoto K; Mabuchi S; Tomimatsu T; Yoshino K; Kimura T
    BMC Womens Health; 2022 Jun; 22(1):229. PubMed ID: 35701778
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frailty Improvement by Multicomponent Drug, Ninjin'Yoeito, in Mild Cognitive Impairment and Mild Alzheimer's Disease Patients: An Open-Label Exploratory Study (FRAMINGO).
    Okahara K; Ohsawa M; Haruta-Tsukamoto A; Miyoshi R; Funahashi H; Fukutani Y; Makita S; Matsuo H; Ishida Y
    J Alzheimers Dis Rep; 2023; 7(1):107-117. PubMed ID: 36891253
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A retrospective study on the efficacy of Ninjin'yoeito on fatigue in patients with interstitial pneumonia.
    Kushima H; Kinoshita Y; Fujita M; Ishii H
    Neuropeptides; 2021 Oct; 89():102178. PubMed ID: 34298370
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluating the Practicality of Causal Inference From Non-randomized Observational Data in Small-Scale Clinical Settings: A Study on the Effects of Ninjin'yoeito.
    Okui N
    Cureus; 2024 Mar; 16(3):e55825. PubMed ID: 38463406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ninjin'yoeito in the Management of Frailty and Overactive Bladder in Elderly Women: A Report of Two Cases.
    Okui N
    Cureus; 2024 Sep; 16(9):e69304. PubMed ID: 39398850
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of Ninjin'yoeito on Patients with Chronic Obstructive Pulmonary Disease and Comorbid Frailty and Sarcopenia: A Preliminary Open-Label Randomized Controlled Trial.
    Ohbayashi H; Ariga M; Ohta K; Kudo S; Furuta O; Yamamoto A
    Int J Chron Obstruct Pulmon Dis; 2024; 19():995-1010. PubMed ID: 38737191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Herbal Medicine Ninjin'yoeito in the Treatment of Sarcopenia and Frailty.
    Uto NS; Amitani H; Atobe Y; Sameshima Y; Sakaki M; Rokot N; Ataka K; Amitani M; Inui A
    Front Nutr; 2018; 5():126. PubMed ID: 30619872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Clinical Study of Ninjin'yoeito With Regard to Frailty.
    Sakisaka N; Mitani K; Sempuku S; Imai T; Takemoto Y; Shimomura H; Ushiroyama T
    Front Nutr; 2018; 5():73. PubMed ID: 30320119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ninjin'yoeito reduces fatigue-like conditions by alleviating inflammation of the brain and skeletal muscles in aging mice.
    Otsuka S; Matsuzaki R; Kakimoto S; Tachibe Y; Kawatani T; Takada S; Tani A; Nakanishi K; Matsuoka T; Kato Y; Inadome M; Nojima N; Sakakima H; Mizuno K; Matsubara Y; Maruyama I
    PLoS One; 2024; 19(5):e0303833. PubMed ID: 38768175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.